Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia

Journal of Gastroenterology and Hepatology (Australia)

Volumn 23, Issue 3, 2008, Pages 474-481

  Elkady, Abeer ^a   Tanaka, Yasuhito ^a   Kurbanov, Fuat ^a   Oynsuren, Tsendsuren ^b   Mizokami, Masashi ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b INSTITUTE OF CHEMISTRY AND CHEMICAL TECHNOLOGY   (Mongolia)

Author keywords

Genotype; Hepatitis B virus; Mutation

Indexed keywords

CYSTEINE; GLYCINE; HEPATITIS B CORE ANTIGEN; HEPATITIS B(E) ANTIGEN; THREONINE; VALINE; VIRUS DNA;

ADULT; ARTICLE; CHRONIC LIVER DISEASE; CLINICAL FEATURE; CODON; ENZYME IMMUNOASSAY; FEMALE; GENE MUTATION; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MONGOLIA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEROLOGY; UNINDEXED SEQUENCE; VIRUS CORE; VIRUS INFECTION; VIRUS LOAD; VIRUS STRAIN;

EID: 40349103941     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2008.05321.x     Document Type: Article

References (47)

1. 1 Chen DS. From hepatitis to hepatoma: lessons from type B viral hepatitis. Science 1993 ; 262: 369–70.
2. 2 Miyakawa Y, Mizokami M. Classifying hepatitis B virus genotypes. Intervirology 2003 ; 46: 329–38.
3. 3 Takahashi K, Ohta Y, Kanai K et al. Clinical implications of mutations C‐to‐T1653 and T‐to‐C/A/G1753 of hepatitis B virus genotype C genome in chronic liver disease. Arch. Virol. 1999 ; 144: 1299–308.
4. 4 Kao JH, Chen PJ, Lai MY, Chen DS. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology 2003 ; 124: 327–34.
5. 5 Oyunsuren T, Kurbanov F, Tanaka Y et al. High frequency of hepatocellular carcinoma in Mongolia; association with mono‐, or co‐infection with hepatitis C, B, and delta viruses. J. Med. Virol. 2006 ; 78: 1688–95.
6. 6 Tsatsralt‐Od B, Takahashi M, Nishizawa T, Endo K, Inoue J, Okamoto H. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia. J. Med. Virol. 2005 ; 77: 491–9.
7. 7 Kurbanov F, Tanaka Y, Elkady A, Oyunsuren T, Mizokami M. Tracing hepatitis C and Delta viruses to estimate their contribution in HCC rates in Mongolia. J. Viral. Hepat. 2008 ; 14: 327–34. doi:101111/j1365‐2893200700864x.
8. 8 Norder H, Courouce AM, Magnius LO. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 1994 ; 198: 489–503.
9. 9 Okamoto H, Tsuda F, Sakugawa H et al. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J. Gen. Virol. 1988 ; 69 (Pt 10): 2575–83.
10. 10 Stuyver L, De Gendt S, Van Geyt C et al. A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J. Gen. Virol. 2000 ; 81: 67–74.
11. 11 Thakur V, Guptan RC, Kazim SN, Malhotra V, Sarin SK. Profile, spectrum and significance of HBV genotypes in chronic liver disease patients in the Indian subcontinent. J. Gastroenterol. Hepatol. 2002 ; 17: 165–70.
12. 12 Gandhe SS, Chadha MS, Arankalle VA. Hepatitis B virus genotypes and serotypes in western India: lack of clinical significance. J. Med. Virol. 2003 ; 69: 324–30.
13. 13 Yalcin K, Degertekin H, Bahcecioglu IH et al. Hepatitis B virus genotype D prevails in patients with persistently elevated or normal ALT levels in Turkey. Infection 2004 ; 32: 24–9.
14. 14 Bahri O, Cheikh I, Hajji N et al. Hepatitis B genotypes, precore and core promoter mutants circulating in Tunisia. J. Med. Virol. 2006 ; 78: 353–7.
15. 15 Gunther S, Fischer L, Pult I, Sterneck M, Will H. Naturally occurring variants of hepatitis B virus. Adv. Virus Res. 1999 ; 52: 25–137.
16. 16 Baumert TF, Rogers SA, Hasegawa K, Liang TJ. Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication. J. Clin. Invest. 1996 ; 98: 2268–76.
17. 17 Ahn SH, Kramvis A, Kawai S et al. Sequence variation upstream of precore translation initiation codon reduces hepatitis B virus e antigen production. Gastroenterology 2003 ; 125: 1370–8.
18. 18 Tanaka Y, Hasegawa I, Kato T et al. A case‐control study for differences among hepatitis B virus infections of genotypes A (subtypes Aa and Ae) and D. Hepatology 2004 ; 40: 747–55.
19. 19 Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004 ; 127: S5–16.
20. 20 Usuda S, Okamoto H, Iwanari H et al. Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type‐specific epitopes in the preS2‐region product. J. Virol. Methods 1999 ; 80: 97–112.
21. 21 Kimura T, Rokuhara A, Matsumoto A et al. New enzyme immunoassay for detection of hepatitis B virus core antigen (HBcAg) and relation between levels of HBcAg and HBV DNA. J. Clin. Microbiol. 2003 ; 41: 1901–6.
22. 22 Kimura T, Rokuhara A, Sakamoto Y et al. Sensitive enzyme immunoassay for hepatitis B virus core‐related antigens and their correlation to virus load. J. Clin. Microbiol. 2002 ; 40: 439–45.
23. 23 Abe A, Inoue K, Tanaka T et al. Quantitation of hepatitis B virus genomic DNA by real‐time detection PCR. J. Clin. Microbiol. 1999 ; 37: 2899–903.
24. 24 Sugauchi F, Mizokami M, Orito E et al. A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: complete genome sequence and phylogenetic relatedness. J. Gen. Virol. 2001 ; 82: 883–92.
25. 25 Thompson JD, Higgins DG, Gibson TJ. Clustal W improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position‐specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994 ; 22: 4673–80.
26. 26 Gojobori T, Ishii K, Nei M. Estimation of average number of nucleotide substitutions when the rate of substitution varies with nucleotide. J. Mol. Evol. 1982 ; 18: 414–23.
27. 27 Lole KS, Bollinger RC, Paranjape RS et al. Full‐length human immunodeficiency virus type 1 genomes from subtype C‐infected seroconverters in India, with evidence of intersubtype recombination. J. Virol. 1999 ; 73: 152–60.
28. 28 Wang Z, Liu Z, Zeng G et al. A new intertype recombinant between genotypes C and D of hepatitis B virus identified in China. J. Gen. Virol. 2005 ; 86: 985–90.
29. 29 Tanaka Y, Mukaide M, Orito E et al. Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma. J. Hepatol. 2006 ; 45: 646–53.
30. 30 Parekh S, Zoulim F, Ahn SH et al. Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants. J. Virol. 2003 ; 77: 6601–12.
31. 31 Lin X, Xu X, Huang QL et al. Biological impacts of ‘hot‐spot’ mutations of hepatitis B virus X proteins are genotype B and C differentiated. World J. Gastroenterol. 2005 ; 11: 4703–8.
32. 32 Murakami S. Hepatitis B virus X protein: a multifunctional viral regulator. J. Gastroenterol. 2001 ; 36: 651–60.
33. 33 Sirma H, Giannini C, Poussin K, Paterlini P, Kremsdorf D, Brechot C. Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. Oncogene 1999 ; 18: 4848–59.
34. 34 Ozer A, Khaoustov VI, Mearns M et al. Effect of hepatocyte proliferation and cellular DNA synthesis on hepatitis B virus replication. Gastroenterology 1996 ; 110: 1519–28.
35. 35 Bonilla Guerrero R, Roberts LR. The role of hepatitis B virus integrations in the pathogenesis of human hepatocellular carcinoma. J. Hepatol. 2005 ; 42: 760–77.
36. 36 Wu JC, Chen PJ, Kuo MY, Lee SD, Chen DS, Ting LP. Production of hepatitis delta virus and suppression of helper hepatitis B virus in a human hepatoma cell line. J. Virol. 1991 ; 65: 1099–104.
37. 37 Sagnelli E, Coppola N, Scolastico C et al. Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis. Hepatology 2000 ; 32: 1106–10.
38. 38 Jardi R, Rodriguez F, Buti M et al. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference. Hepatology 2001 ; 34: 404–10.
39. 39 Baptista M, Kramvis A, Kew MC. High prevalence of 1762(T) 1764 (A) mutations in the basic core promoter of hepatitis B virus isolated from black Africans with hepatocellular carcinoma compared with asymptomatic carriers. Hepatology 1999 ; 29: 946–53.
40. 40 Bozdayi AM, Bozkaya H, Turkyilmaz AR et al. Nucleotide divergences in the core promoter and precore region of genotype D hepatitis B virus in patients with persistently elevated or normal ALT levels. J. Clin. Virol. 2001 ; 21: 91–101.
41. 41 Sendi H, Mehrab‐Mohseni M, Zali MR, Norder H, Magnius LO. T1764G1766 core promoter double mutants are restricted to Hepatitis B virus strains with an A1757 and are common in genotype D. J. Gen. Virol. 2005 ; 86: 2451–8.
42. 42 Chu CJ, Keeffe EB, Han SH et al. Prevalence of HBV precore/core promoter variants in the United States. Hepatology 2003 ; 38: 619–28.
43. 43 Orito E, Mizokami M, Sakugawa H et al. A case‐control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group. Hepatology 2001 ; 33: 218–23.
44. 44 Sugauchi F, Orito E, Ichida T et al. Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C. Gastroenterology 2003 ; 124: 925–32.
45. 45 Orito E, Sugauchi F, Tanaka Y et al. Differences of hepatocellular carcinoma patients with hepatitis B virus genotypes of Ba, Bj or C in Japan. Intervirology 2005 ; 48: 239–45.
46. 46 Buckwold VE, Xu Z, Chen M, Yen TS, Ou JH. Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication. J. Virol. 1996 ; 70: 5845–51.
47. 47 Liu CJ, Chen BF, Chen PJ et al. Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers. J. Infect. Dis. 2006 ; 193: 1258–65.